top of page
City Sky
This is your Testimonial quote. Give your customers the stage to tell the world how great you are!

Frankie B.

This is your Testimonial quote. Give your customers the stage to tell the world how great you are!

Jesse N.

This is your Testimonial quote. Give your customers the stage to tell the world how great you are!

Jamie L.

CASE STUDIES

Selected examples of how USDDR improves access, execution, and growth across channels.

Launching a Global Device Manufacturer into the U.S. Market

Global Device Manufacturer 

No US presence and little understanding of the US markets

In 2018, a global DEVICE manufacturer of respiratory spacers (attachment for inhalers to allow more medicine to reach the lungs) contracted with USDDR to launch 4 SKUs in the US.  The client had no U.S. market presence and limited understanding of the U.S. healthcare ecosystem—including reimbursement, distribution, payer dynamics, and institutional access.

doctor showing child how to use inhaler with a respiratory spacer.jpg

Results

51% 6-Year CAGR

$7M Revenue Increase in 6 Years

Unlocking Institutional Growth

Global CPG manufacturer

Seeking new, scalable revenue streams beyond traditional retail

A global CPG manufacturer with leading consumer brands sought new, scalable revenue streams beyond traditional retail. While some unmanaged institutional sales existed, the organization lacked a clear strategy to penetrate higher-margin healthcare channels such as hospitals, long-term care, and military.

Sorting Medicine

Results

329% growth in first full year
156% 4-Year CAGR

Expanding Institutional Market Penetration

Global Med-Surg Manufacturer 

Looking to Drive Sales in the Institutional Markets

A global Med-Surg manufacturer with established, high-performing brands was underpenetrated in institutional markets. Despite working with an existing agency, results were limited, with only partial GPO access and underutilization of their 11-SKU pain management portfolio.

Nucleoplasty

Results

167% Full Year Sales Growth

3x increase in contracts

Turning Prescription Decline into Sustained Growth

Small Pharmaceutical Manufacturer

 Facing -1% Full Year Declines

Declining prescription performance, finishing the year at -1% growth, with increasing pharmacy switching and limited visibility across key systems.

Girl in Pharmacy

Results

Turned Positive in 90 Days
7% CAGR

bottom of page